Age‐dependent prevalence of type 2 diabetes, cardiovascular risk profiles and use of diabetes drugs in Germany using health claims data
Authors' conclusion
T2DM is widespread and affects older patients particularly. Most patients with T2DM had at least one CV risk factor, and about half already had established CVD. Early prevention of CVD, which disproportionately affects patients with T2DM, is necessary. Furthermore, the treatment of older patients with T2DM with insulin is still common and needs further evaluation.
Study context
- Population
- Patients with T2D in German claims data (WIG2 database), 2018; treatment regimens evaluated in patients at risk for or with established cardiovascular disease (CVD) per REWIND criteriaeligible in database
- Participants
- 3,376,228 patients
- Outcome
- T2D prevalence
- Follow-up
- 2018
Methodological detailshealth claims data, WIG2 database, extrapolated to German statutory health insurance population
- Health claims data
- WIG2 database
- Extrapolated to German statutory health insurance population
Main finding
As reported in the abstract
Extrapolated T2D prevalence
11.9%
Prevalence counting only patients with antidiabetic drug prescriptions
7.6%
Observational data: associations, not effects.
Further findings
REWIND risk factors in patients with T2D medication
- ≥1 risk factor (without considering age)
- At least 94%
- ≥2 risk factors, depending on treatment
- 67%-80%
- Insulin plus oral therapy: largest proportion with ≥2 REWIND risk factors
Antihypertensive medication use in all patients with T2D
- Treated with antihypertensive medication
- ≈85%
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →